• Privacy Policy
  • About Us
  • Contact Us
  • Home
  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
No Result
View All Result
  • Home
  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
No Result
View All Result
Cartographeum
No Result
View All Result

Dr. Reddy’s launches COVID-19 drug Remdesivir

Juliet Woodard by Juliet Woodard
September 9, 2020
Home Business
Share on FacebookShare on Twitter

Redyx is available in strength of 100 mg vial, the company said.

Drugmaker Dr. Reddy’s Laboratories has launched Gilead Sciences Remdesivir, an investigational drug used in the treatment of COVID-19, under the brand name Redyx in India. Drugs Controller General of India (DCGI) has approved Remdesivir for restricted emergency use in the treatment of COVID-19 patients hospitalised with severe symptoms.Dr.Reddy’s said the launch is part of the licensing agreement with Gilead Sciences Inc. that grants it the right to register, manufacture and sell Remdesivir in 127 countries, including India.Redyx is available in strength of 100 mg vial, the company said.CEO, Branded Markets (India and Emerging Markets) at Dr. Reddy’s M.V.Ramana said, “We will continue our efforts to develop products that address significant unmet needs of patients. The launch of Redyx reaffirms our commitment to bringing in critical medicine for patients suffering from COVID-19 in India.”

You have reached your limit for free articles this month.
To get full access, please subscribe.
Already have an account ? Sign in

Show Less Plan

Subscription Benefits Include

Today’s Paper
Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages
Move smoothly between articles as our pages load instantly.

Unlimited Access
Enjoy reading as many articles as you wish without any limitations.

Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations
A select list of articles that match your interests and tastes.

Briefing
We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

A letter from the Editor
Dear subscriber,Thank you!Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.Suresh Nambath

Tags: coronavirus drugDr. Reddy’s Laboratoriesredyxremdesivir
Juliet Woodard

Juliet Woodard

Next Post
Amazfit Neo Retro-Style Smartwatch Debuts With Over 4 Weeks of Battery Life

Amazfit Neo Retro-Style Smartwatch Debuts With Over 4 Weeks of Battery Life

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

Gold plunges ₹ 1,492, silver tanks ₹ 1,476

Apprentice hiring set to increase, says report

October 27, 2020
What The Rise Of Digital Nomads Means For Destination Real Estate

What The Rise Of Digital Nomads Means For Destination Real Estate

February 3, 2021

Trending.

Understanding Emergency Rental Assistance For Landlords And Tenants

Understanding Emergency Rental Assistance For Landlords And Tenants

January 27, 2021
Call of the mall – The Hindu

Call of the mall – The Hindu

October 16, 2020
Facebook Bars Deceptive Campaign From Pro-Trump Group

Facebook Bars Deceptive Campaign From Pro-Trump Group

October 10, 2020
Nirmala Sitharaman press meet live | Centre announces Atmanirbhar Bharat Rozgar Yojana for formal sector

Nirmala Sitharaman press meet updates | Finance Minister announces 12 schemes to boost economy

November 12, 2020
Missing Middle Housing Is A Huge Opportunity Offering Resilient Investment And High Demand

Missing Middle Housing Is A Huge Opportunity Offering Resilient Investment And High Demand

February 17, 2021

Cartographeum brings you the latest information about Tech,Real Estate & Business.

Follow Us

Categories

  • Business
  • Computers
  • Gear
  • Real Estate
  • Review
  • Technology
  • Uncategorized

Tags

Amazon Apple Watch 2 Bombay stock exchange BSE Business Buying Guides china closing trade coronavirus Covid COVID-19 currency dollar rate economy Finance Ministry foreign exchange forex gold india indian economy Indian stock market Industry iOS 10 lockdown luxury homes market and exchange markets nifty Nirmala Sitharaman NSE oil pandemic Playstation 4 Pro rbi real estate Reserve Bank of India rupee rupee rate Rupee value rupee vs dollar sensex Sillicon Valley stock exchange Stocks USD

Recent News

How Your ‘Free’ Buyer’s Agent Increases The Cost Of Homeownership (And What Homebuyers Can Do)

How Can Landlords Prepare For 2021?

March 5, 2021
Jimmy Fallon Puts His Manhattan Home On The Market For $15 Million

Jimmy Fallon Puts His Manhattan Home On The Market For $15 Million

March 5, 2021
  • Privacy Policy
  • About Us
  • Contact Us

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.

No Result
View All Result
  • Home
  • Review
  • Computers
  • Gear

© 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.